TGFB1 and neoplasm: The fact that TGF-β, miRs, and HIFs regulate multiple targets associated with increased tumor angiogenesis, immune evasion, and drug resistance highlights the unmet need to delineate the underlying mechanisms and to develop potent and selective inhibitors.